Related Experiment Video
Updated: Mar 15, 2026

04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.3K
Using LASSO Regression to Predict Rheumatoid Arthritis Treatment Efficacy
David J Odgers1, Natalie Tellis1, Heather Hall1
1Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA.
Summary
This study introduces a novel method for predicting rheumatoid arthritis (RA) treatment outcomes using electronic health records and linked data. This approach aims to improve patient management and reduce healthcare burdens.
Area of Science:
- * Biomedical informatics
- * Clinical informatics
- * Rheumatology
Background:
- * Rheumatoid arthritis (RA) is a leading cause of disability and mortality in the US.
- * Current RA treatment guidelines lack drug efficacy prediction.
- * Understanding autoimmune disorder mechanisms and patient variability poses treatment challenges.
Purpose of the Study:
- * To develop and demonstrate a method for classifying patient outcomes in rheumatoid arthritis.
- * To leverage Electronic Health Records (EHR) and Biomedical Linked Open Data (LOD) for improved treatment prediction.
- * To provide insights into differential drug treatment outcomes.
Main Methods:
- * Utilized LASSO penalized regression for patient outcome classification.
- * Integrated Electronic Health Records (EHR) with Biomedical Linked Open Data (LOD).
- * Developed a predictive model for treatment success.
Main Results:
- * Demonstrated that Linked Data enhances prediction accuracy for RA patient outcomes.
- * Identified insights into how different drug treatment regimens affect outcomes.
- * Showcased the potential of machine learning classifiers in clinical decision support.
Conclusions:
- * The proposed method using EHR and LOD can classify RA patient outcomes effectively.
- * This approach offers potential for improving clinical decision-making in RA management.
- * Successful application could reduce the physical and financial burden of RA on patients and healthcare systems.

